Institute of Digestive Disease, The Chinese University of Hong Kong, Shatin, Hong Kong.
Aliment Pharmacol Ther. 2010 Feb 1;31(3):452-60. doi: 10.1111/j.1365-2036.2009.04187.x. Epub 2009 Oct 31.
BACKGROUND: A simple and meaningful health-related quality of life (HRQoL) questionnaire for gastro-oesophageal reflux disease (GERD) patients is lacking. AIM: To develop and validate a disease-specific HRQoL instrument (GERD-QOL) for GERD patients. METHODS: An 18-item questionnaire was generated to measure the impact of GERD on sleep, exercise, diet, need for medication, sex life, work, social activity and psychological well-being. GERD patients were invited to complete the GERD-QOL, a visual analogue scale (VAS) and a validated Chinese generic QoL (SF-36) questionnaire before and after esomeprazole treatment. Factor analysis was performed for item selection and psychometric properties were measured. An English version was developed by a forward-backward translation process. RESULTS: A final 16-item GERD-QOL questionnaire was developed. The items were grouped into four subscales (Daily activity, Treatment effect, Diet, and Psychological well-being) after factor analysis. GERD-QOL had good item-internal consistency (Cronbach's alpha: 0.64-0.88), high test-retest reliability (intraclass correlation coefficient: 0.73-0.94, P < 0.001). Its subscale scores were correlated with SF-36 and VAS, which demonstrated high construct validity (P < 0.001). Discriminant validity was verified by correlating GERD-QOL scores with symptom severity (P < 0.001). Responsiveness after esomeprazole treatment was significant (paired-t-test P < 0.001). An English version of GERD-QOL was developed. CONCLUSION: The instrument, GERD-QOL, is valid and reliable.
背景:目前缺乏针对胃食管反流病(GERD)患者的简单而有意义的健康相关生活质量(HRQoL)问卷。
目的:开发和验证一种针对 GERD 患者的特定疾病 HRQoL 工具(GERD-QOL)。
方法:生成了一个包含 18 个条目的问卷,用于衡量 GERD 对睡眠、运动、饮食、药物需求、性生活、工作、社交活动和心理幸福感的影响。在埃索美拉唑治疗前后,邀请 GERD 患者完成 GERD-QOL、视觉模拟量表(VAS)和经过验证的中文通用生活质量(SF-36)问卷。进行了因子分析以选择项目,并测量了心理测量学特性。通过正向-反向翻译过程开发了英文版本。
结果:开发了最终的 16 项 GERD-QOL 问卷。通过因子分析,项目被分为四个亚量表(日常活动、治疗效果、饮食和心理幸福感)。GERD-QOL 具有良好的项目内部一致性(Cronbach's alpha:0.64-0.88)和高测试-重测信度(组内相关系数:0.73-0.94,P < 0.001)。其亚量表评分与 SF-36 和 VAS 相关,表明具有较高的结构效度(P < 0.001)。通过与症状严重程度相关(P < 0.001)验证了判别效度。埃索美拉唑治疗后的反应性具有统计学意义(配对 t 检验,P < 0.001)。开发了 GERD-QOL 的英文版本。
结论:该工具 GERD-QOL 具有有效性和可靠性。
Aliment Pharmacol Ther. 2004-10-15
Eur J Gastroenterol Hepatol. 2008-3
Gastroenterol Hepatol. 2009-1
Aliment Pharmacol Ther. 2008-5
Diagnostics (Basel). 2023-6-14
J Neurogastroenterol Motil. 2018-10-1
Am J Gastroenterol. 2013-12-17